| BSE: 524348 | Sector: Health care |
| NSE: AARTIDRUGS | ISIN Code: INE767A01016 |
| BSE 00:00 | 16 Aug | 459.35 |
-1.60 (-0.35%) |
OPEN
451.00 |
HIGH
461.45 |
LOW
451.00 |
| NSE 00:00 | 16 Aug | 460.15 |
0 (0.00%) |
OPEN
453.30 |
HIGH
462.15 |
LOW
450.00 |
| OPEN | 451.00 |
| PREVIOUS CLOSE | 460.95 |
| VOLUME | 859 |
| 52-Week high | 705.00 |
| 52-Week low | 419.30 |
| P/E | 12.38 |
| Mkt Cap.(Rs cr) | 1,070 |
| Buy Price | 451.00 |
| Buy Qty | 1.00 |
| Sell Price | 464.00 |
| Sell Qty | 1.00 |
10.41 pm | 18 Aug 2019 | Business Standard
Sun's focus on specialty comes at a time when its US revenues are under pressure owing to competitive intensity
12.29 am | 18 Aug 2019 | Bloomberg
Novartis has said that it learned of the data manipulation on March 14 and alerted the US Food and Drug Administration
5.57 pm | 17 Aug 2019 | Press Trust of India
In a regulatory filing, Cipla said 99.68% shareholders polled in favour of the resolution to raise funds
12.13 am | 17 Aug 2019 | Business Standard
Promoters say the plan to reduce pledged shares in the firm to 50% in a few months is on track
8.54 pm | 16 Aug 2019 | Business Standard
The total addressable market size for all these eight products is about $1 billion (according to recent IQVIA data) in mainland China
1.03 pm | 16 Aug 2019 | Business Standard
The company's consolidated net profit more than doubled at Rs 49 crore in Q1FY20 as against a PAT of Rs 23 crore in the year ago quarter.
12.16 am | 15 Aug 2019 | Business Standard
In October, the Sebi had directed Fortis to take necessary action to recover Rs 403 cr from Singh brothers
10.33 pm | 14 Aug 2019 | Business Standard
Apart from rationalising costs, the company is also aiming to divest some of its non-core global assets as well as bring in a minority investor in to ...
9.28 pm | 14 Aug 2019 | Business Standard
Firm banking on acquisitions, and rationalisation of prices
2.40 pm | 14 Aug 2019 | Press Trust of India
The pact is for patents related to certain compounds with potential therapeutic activity across multiple indications
12.49 pm | 14 Aug 2019 | Press Trust of India
Total income of the company stood at Rs 871.19 crore during the quarter under review
11.48 am | 14 Aug 2019 | Business Standard
Glenmark Pharmaceuticals plunged 9 per cent, while Dr Reddy's slipped 8 per cent in intra-day trade
11.48 am | 14 Aug 2019 | Business Standard
Glenmark Pharmaceuticals plunged 9 per cent, while Dr Reddy's slipped 8 per cent in intra-day trade
11.48 am | 14 Aug 2019 | Business Standard
Glenmark Pharmaceuticals plunged 9 per cent, while Dr Reddy's slipped 8 per cent in intra-day trade
11.48 am | 14 Aug 2019 | Business Standard
Glenmark Pharmaceuticals plunged 9 per cent, while Dr Reddy's slipped 8 per cent in intra-day trade
11.48 am | 14 Aug 2019 | Business Standard
Glenmark Pharmaceuticals plunged 9 per cent, while Dr Reddy's slipped 8 per cent in intra-day trade
10.51 am | 14 Aug 2019 | Business Standard
A CRL is issued when the FDA decides not to approve new or generic drug application for marketing in its present form
7.56 am | 14 Aug 2019 | Business Standard
Here are the weekly stock recommendations by Religare Broking
7.47 am | 14 Aug 2019 | Business Standard
Nifty outlook and top trading ideas by Vinay Rajani - Technical Analyst, HDFC Securities.
3.04 am | 14 Aug 2019 | Business Standard
The company's total income stood at Rs 2,233.94 cr during the quarter, as against Rs 1,912.44 cr in the corresponding quarter last year, a growth of 1...
